Zhong introduces convalescence plasma trial in COVID-19 treatment

Updated: Mar 31, 2020 chinadaily.com.cn Print

Share - WeChat

In a video consultation with US medical experts on Friday, Zhong Nanshan, a prominent Chinese respiratory disease expert, introduced convalescence plasma trial in treating the COVID-19 in China.

Editors' Picks

Infographic: 166 foreign-invested enterprises approved for value-added telecom services

Infographic: China improves departure tax refund services to boost inbound consumption

Infographic: China-US cooperation: Mutual benefits, broad reach

Infographic: China-US economic ties: The path ahead

Posters: Policies concerning expats, foreign enterprises in April 2026

Zhong introduces convalescence plasma trial in COVID-19 treatment

MOST POPULAR

Editors' Picks

LEAVE YOUR MESSAGE

*Your E-mail Address